Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.2. Drivers
4.2.1. Rising incidences of toxoplasmosis
4.2.2. Increasing demand for effective testing methods
4.3. Restraints
4.3.1. High cost associated with these products
4.4. Opportunities
4.5. Impact Analysis
5. Industry Factors
5.1. Porter’s Five Forces
5.2. Regulator Analysis
5.3. Supply Chain Analysis
5.4. Pricing Analysis
6. By Test Type
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
6.1.2. Market Attractiveness Index, By Test Type
6.2. Serological test
6.2.1. Introduction
6.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
6.2.3. Dye Test
6.2.4. Indirect Immune Fluorescent Test (IFAT)
6.2.5. Modified Agglutination Test (MAT)
6.2.6. Enzyme-Linked Immunosorbent Assay (ELISA)
6.2.7. Immunoglobulin Tests (IgG, IgM, and IgE antibodies Tests)
6.2.8. Indirect Hemagglutination Assay
6.2.9. Direct Agglutination Test
6.3. Others (PCR, others)
7. By Sample Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sample Type
7.1.2. Market Attractiveness Index, By Sample Type
7.2. Blood Sample
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Amniotic Fluid
7.4. Cerebrospinal Fluid
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospital
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Diagnostic Laboratories
8.4. Clinics
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sample Type
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Use
9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. The U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. South America
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sample Type
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Use
9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Brazil
9.3.6.2. Argentina
9.3.6.3. Rest of South America
9.4. Europe
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sample Type
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Use
9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Germany
9.4.6.2. The U.K.
9.4.6.3. France
9.4.6.4. Spain
9.4.6.5. Italy
9.4.6.6. Rest of Europe
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sample Type
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Use
9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. Australia
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East & Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sample Type
9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Use
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. ACON Laboratories
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. Biokit
11.3. Biom?rieux
11.4. Bionote
11.5. Atlas Medical
11.6. LifeSpan BioSciences
11.7. Elitechgroup
11.8. Genemedi Suzhou Biotechnology
11.9. Gold Standard Diagnostic
11.10. Thermo Fisher Scientific
11.11. Abbott Laboratories
11.12. Bio-Rad Laboratories Inc.
11.13. Diasorin S.p.A.
LIST NOT EXHAUSTIVE
12. Global Toxoplasmosis Testing Market – DataM
12.1. Appendix
12.2. About Us and Method of Fixation
12.3. Contact Us